We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian public assessment report (AusPar)Letybo (letibotulinumtoxinA) has been approved for temporary improvement in the appearance of glabellar frown lines in adults.
-
Prescription medicine decision summaryTGA decision: Letybo (letibotulinumtoxinA) is approved to treat the appearance of moderate to severe glabellar frown lines in adults.
-
Prescription medicine registrationActive ingredients: letibotulinumtoxinA.